Press Releases IntegraGen

Equities

ALINT

FR0010908723

Market Closed - Euronext Paris Other stock markets 07:17:19 03/05/2024 pm IST			5-day change	1st Jan Change
0.595 ^EUR	+1.71%		+0.85%	-33.45%

2023	IntegraGen SA Reports Earnings Results for the Half Year Ended June 30, 2023	CI
2023	IntegraGen SA Announces Revenue Results for the First Half of 2023	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

IntegraGen: Annual Results 2023 - Positive EBITDA Reflecting Tight Cost Control	18/04	BU
IntegraGen : reports 2022 annual results with a growth of 16% in revenues and a positive EBITDA.	24/23/24	PU
IntegraGen : Inside Information / Information on annual revenues	13/23/13	PU
IntegraGen : reports 6.4 M€ in revenues for the first half of 2022 representing 34% growth compared to H1 2021. Cash position of 4.5 M€.	13/22/13	PU
IntegraGen : reports 2021 annual results with a strong growth of 20% in revenue from current operations and a significant profitability improvement	29/22/29	PU
2021 revenue: €10.9 million, a strong growth by +21% compared to 2020, and cash position of €4.8 million	14/22/14	PU
IntegraGen reports 2020 annual results: 10% growth in revenue from current operations and achievement of breakeven operating profits	19/21/19	PU
IntegraGen : reports 2020 revenue of €9.0 million, an increase of +10%, and a cash position of €5.0 million as of December 31, 2020	12/21/12	PU
IntegraGen : Reports Results for 1st Half of 2020	18/20/18	PU
IntegraGen : ONCODNA Provides an Update About the Friendly Takeover Bid on INTEGRAGEN	13/20/13	BU
IntegraGen : Agreement to file a friendly takeover bid initiated by ONCODNA on INTEGRAGEN	09/20/09	PU
IntegraGen : Agreement to File a Friendly Takeover Bid Initiated by ONCODNA on INTEGRAGEN to Acquire All Outstanding Shares at a Price of 2.20€ Per Share	09/20/09	BU
IntegraGen : reports sales of €4.7 million in the first half of 2020, up 13%, and cash position of €5.8 million	09/20/09	BU
IntegraGen : reports 2019 annual results	03/20/03	PU
IntegraGen : Announces Leading U.S. Cancer Center to Use MERCURY™ Cloud-based Tool for Oncology Sequencing Data Interpretation and Reporting	26/20/26	BU
IntegraGen : announces 2019 revenue of €8.3 million, up +20%, and cash position of €2.8 million as of December 31	10/20/10	PU
IntegraGen : Press release on General Assembly voting results	30/19/30	PU
IntegraGen : Announces Publication of of miR-31-3p Data in Clinical Cancer Research	04/18/04	PU
IntegraGen : Announces Publication of Data Which Demonstrates the Ability of miR-31-3p to Predict Response to Therapy for Patients with Metastatic Colorectal Cancer	04/18/04	BU
IntegraGen : The SeqOIA Cooperative Health Group Selects IntegraGen As the Operator of Its Sequencing Platform as Part of the France Genomic Medicine 2025 Plan	31/18/31	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases IntegraGen

Equities

ALINT

FR0010908723

Press Releases

Filters